Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- befree-2016 importedOn "2016-02-19" NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_assertion wasGeneratedBy ECO_0000203 NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_assertion wasDerivedFrom befree-2016 NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_assertion SIO_000772 22279054 NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_assertion evidence source_evidence_literature NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.
- NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_assertion description "[The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956170.RA79nTn5TM1teh2ZisRxOsRnBOFko9J9cQrG0ahE-o5X4130_provenance.